Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02658279
Brief Title: Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

First Submitted : January 12, 2016
First Submitted that Met QC Criteria : January 14, 2016
First Posted : January 18, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 24, 2021
Last Update Posted : February 25, 2021